Skip to content
Menu
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

RVL Pharmaceuticals plc RVLPQ

Full chart Compare
Set alert

Price alert · RVLPQ

All alert types
0.00 USD 0.00 (+0.00%)

Regular-session close

0.000001 Day range 0.0005
0.000001 52-week range 0.0005
YTD
0.00%
1 year
0.00%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Sign in

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Sign in

Financial health

Altman Z-Score

-12.26 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.9×
FY 2016: -8.3×FY 2017: -7.8×FY 2018: -3.2×FY 2019: -1.4×FY 2020: -2.8×FY 2021: -0.9×FY 2022: -1.9×
FY 2016 5y median -1.9× FY 2022
P/S 2.0×
FY 2016: 1.6×FY 2017: 1.4×FY 2018: 1.3×FY 2019: 1.5×FY 2020: 9.0×FY 2021: 4.2×FY 2022: 2.0×
FY 2016 5y median 2.0× FY 2022
P/B 2.0×
FY 2016: 0.8×FY 2017: 0.8×FY 2018: 0.9×FY 2019: 3.2×FY 2020: 2.7×FY 2021: 0.9×FY 2022: 2.0×
FY 2016 5y median 2.0× FY 2022
P/FCF -2.6×
FY 2016: -5.8×FY 2017: 6.9×FY 2018: 10.5×FY 2019: 12.4×FY 2020: 17.3×FY 2021: -1.3×FY 2022: -2.6×
FY 2016 5y median 10.5× FY 2022
EV/EBITDA -2.4×
FY 2016: 30.5×FY 2017: 10.1×FY 2018: -0.8×FY 2019: -10.9×FY 2020: -5.1×FY 2021: -1.1×FY 2022: -2.4×
FY 2016 5y median -2.4× FY 2022
EV/Sales 2.3×
FY 2016: 3.0×FY 2017: 2.6×FY 2018: 2.1×FY 2019: 2.3×FY 2020: 12.9×FY 2021: 4.6×FY 2022: 2.3×
FY 2016 5y median 2.3× FY 2022
FCF Yield -38.3%
FY 2016: -17.4%FY 2017: 14.6%FY 2018: 9.5%FY 2019: 8.1%FY 2020: 5.8%FY 2021: -77.7%FY 2022: -38.3%
FY 2016 5y median 5.8% FY 2022

Profitability

Gross Margin 81.0%
FY 2016: 42.5%FY 2017: 49.1%FY 2018: 46.9%FY 2019: 53.5%FY 2020: 88.1%FY 2021: 79.3%FY 2022: 81.0%
FY 2016 5y median 79.3% FY 2022
Operating Margin -91.9%
FY 2016: -14.7%FY 2017: -21.2%FY 2018: -37.4%FY 2019: 1.6%FY 2020: -222.4%FY 2021: -460.0%FY 2022: -91.9%
FY 2016 5y median -91.9% FY 2022
Net Margin -104.0%
FY 2016: -19.1%FY 2017: -18.4%FY 2018: -41.6%FY 2019: -112.9%FY 2020: -320.6%FY 2021: -473.4%FY 2022: -104.0%
FY 2016 5y median -112.9% FY 2022
ROE -101.2%
FY 2016: -9.0%FY 2017: -10.8%FY 2018: -28.6%FY 2019: -236.2%FY 2020: -94.8%FY 2021: -108.0%FY 2022: -101.2%
FY 2016 5y median -101.2% FY 2022
ROIC -41.3%
FY 2016: -3.0%FY 2017: -3.6%FY 2018: -13.3%FY 2019: 0.9%FY 2020: -18.3%FY 2021: -63.0%FY 2022: -41.3%
FY 2016 5y median -18.3% FY 2022
ROA -40.2%
FY 2016: -4.3%FY 2017: -5.1%FY 2018: -13.8%FY 2019: -58.5%FY 2020: -24.0%FY 2021: -57.3%FY 2022: -40.2%
FY 2016 5y median -40.2% FY 2022

Growth (YoY)

Revenue 184.1%
FY 2016: 0.0%FY 2017: 12.5%FY 2018: 7.3%FY 2019: -9.0%FY 2020: -88.4%FY 2021: -37.0%FY 2022: 184.1%
FY 2016 FY 2022
Operating Income 43.3%
FY 2016: 0.0%FY 2017: -62.5%FY 2018: -89.2%FY 2019: 104.0%FY 2020: -1668.6%FY 2021: -30.4%FY 2022: 43.3%
FY 2016 FY 2022
EPS (diluted) 52.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -146.9%FY 2019: -113.6%FY 2020: 71.6%FY 2021: 16.3%FY 2022: 52.8%
FY 2016 FY 2022
Free Cash Flow 31.8%
FY 2016: 0.0%FY 2017: 183.9%FY 2018: -34.4%FY 2019: -11.6%FY 2020: -51.0%FY 2021: -490.9%FY 2022: 31.8%
FY 2016 FY 2022

Financial Health

Current Ratio 2.9×
FY 2016: 0.8×FY 2017: 0.9×FY 2018: 1.5×FY 2019: 2.3×FY 2020: 3.1×FY 2021: 3.0×FY 2022: 2.9×
FY 2016 5y median 2.9× FY 2022
Quick Ratio 2.8×
FY 2016: 0.6×FY 2017: 0.8×FY 2018: 1.3×FY 2019: 2.0×FY 2020: 3.1×FY 2021: 2.9×FY 2022: 2.8×
FY 2016 5y median 2.8× FY 2022
Debt / Equity 1.1×
FY 2016: 0.7×FY 2017: 0.8×FY 2018: 0.7×FY 2019: 2.4×FY 2020: 2.4×FY 2021: 0.6×FY 2022: 1.1×
FY 2016 5y median 1.1× FY 2022
Net Debt / EBITDA -0.3×
FY 2016: 14.3×FY 2017: 4.5×FY 2018: -0.3×FY 2019: -3.6×FY 2020: -1.5×FY 2021: -0.1×FY 2022: -0.3×
FY 2016 5y median -0.3× FY 2022
Interest Coverage -14.7×
FY 2016: -1.6×FY 2017: -1.8×FY 2018: -4.7×FY 2019: 0.2×FY 2020: -15.1×FY 2021: -20.0×FY 2022: -14.7×
FY 2016 5y median -14.7× FY 2022

Dividends

Dividend Yield 0.0%
FY 2016: 6.7%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016: -55.7%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31